+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 20Years - 60Years
All Genders
ID05610865

Comparing Autologous Fat-Derived Stem Cells and Stromal Vascular Fraction with Platelet Rich Plasma to Treat Chronic Diabetic Foot Ulcers

Led by University of the Punjab · Updated on 2024-12-31

28

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the use of autologous adipose tissue-derived cells combined with platelet rich plasma PRP to treat chronic diabetic foot ulcers. This study aims to compare the therapeutic effectiveness of uncultured stromal vascular fraction SVF cells and cultured adipose derived stem cells ASCs, both supplemented with PRP, which contains factors that support cell survival and wound healing. The study focuses on patients with diabetic neuropathy and chronic foot ulcers, seeking to identify the more effective treatment option while ensuring safety through the use of the patients own cells. Under local or general anesthesia, fat tissue is collected from the patient using manual aspiration. SVF and ASCs are isolated from this tissue through enzymatic digestion, then assessed for quality and cell type before use. PRP is prepared from the patients blood on the day of treatment. Four study groups receive different interventions standard wound care with saline dressings PRP injections alone PRP mixed with SVF cells and PRP mixed with cultured ASCs. The cell and PRP mixture is injected intradermally at the wound border and surface, with dosage based on wound size. Participants will be monitored for three months, with regular interviews and visual checks to assess ulcer healing. The primary outcome is the rate of ulcer recovery, while secondary measures include the percentage of wound closure over time. The study includes assessments like cell quality testing, wound inspections, and patient interviews to track progress. Safety and treatment effects are observed throughout the study period, which lasts up to three months after treatment.

CONDITIONS

Brief Title

Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers

Research Team

A

Azra Mehmood, PhD

A

Amna Arif, M.Phil.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here